Industrials
Specialty Industrial Machinery
$15.68B
8.8K
Key insights and themes extracted from this filing
Net sales decreased to $807.2 million from $846.2 million in the same quarter last year. This decline was attributed to lower volumes, particularly in the Health & Science Technologies segment.
Gross margin increased to 45.4% from 44.7% in the same quarter last year. This increase was due to strong price/cost management and favorable operational productivity, offsetting lower volume leverage and unfavorable mix.
Net income attributable to IDEX increased to $141.3 million from $138.6 million in the same quarter last year. Diluted EPS attributable to IDEX increased to $1.86 from $1.82.